HIV+Hep in the News

Trump administration weighing future of CDC’s HIV prevention division

Carl Schmid, the executive director of the HIV+Hepatitis Policy Institute in Washington, told Reuters he had been told by a government agency source that the division might be shut down and that a decision would be made this week on the funding of HIV prevention at the CDC. Schmid, who co-chaired the Presidential Advisory Council of HIV/AIDS during President Donald Trump’s first term, said he understood all of the division’s funding is “up in the air”.

read more

The business sector’s advocacy to maintain funding for HIV prevention, research, treatment

In late February, The US Business Action to End HIV, the largest coalition of employers dedicated to ending the HIV epidemic in the United States, sent a letter to Congress urging them to prioritize sustained federal funding for HIV prevention and treatment and underscoring the business sector’s commitment to advancing public health and ensuring progress in the fight against HIV. “We have two goals, one to get people who are living with HIV on treatment, and two, to prevent new acquisition of HIV,” said Carl Schmid, Executive Director, HIV+Hepatitis Policy Institute.

read more

Health groups seeking House champion for hep C bill saving $6B

Carl Schmid, executive director of the HIV+Hepatitis Policy Institute, told Inside Health Policy the bill will benefit from public debate. “We of course would like to see a National Hepatitis C Elimination program, but it is important that a program of such magnitude be publicly introduced and debated,” he said. “To date, we have not seen a draft bill but are looking forward to seeing one and reviewing it so that Congress can benefit from the perspective of community members and others.”

read more

Pin It on Pinterest

Share This